BlueCrest Capital Management’s Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share SBII.WS Stock Holding History
Bought
Maintained
Sold
BlueCrest Capital Management's SBII.WS Position: Q4 2022 in Review
BlueCrest Capital Management sold out of Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (SBII.WS) in Q4 2022, closing a stake of 217,955 shares — an estimated $9K sold.
BlueCrest Capital Management first reported a position in SBII.WS in Q3 2021 and held it in 5 quarters. The position peaked at $174K in Q3 2021. 0 funds tracked by Wall St. Rank hold SBII.WS as of Q4 2022.
- BlueCrest Capital Management reported no remaining Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- BlueCrest Capital Management sold 217,955 Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $9K.
- BlueCrest Capital Management first reported a position in Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q3 2021 and held it in 5 quarters.
- BlueCrest Capital Management's Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $174K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on BlueCrest Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.